Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

​​The start up was wholly funded by Oman banks with significant share-holding by Oman investors. It was a major breakthrough in international vaccine pricing and supply to poor countries worldwide. Today the company is a wholly owned subsidiary of Sanofi group of France.

Oman eyes PTA with India; to boost India’s trade ties with Gulf after UAE CEPA

Products in the price control list and growth of the non-power brand portfolio will be key monitorables

Sanofi India: Strong balance sheet, high cash reserves positives for stock

ICICI Direct recommended hold rating on Sanofi India with a target price of Rs 7740 in its research report dated April 27, 2022.

Hold Sanofi India; target of Rs 7740: ICICI Direct

Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9250 in its research report dated April 26, 2022.

Buy Sanofi India: target of Rs 9250: Sharekhan

Sanofi के शानदार रहें Q4 के नतीजे, जानें निवेश को लेकर क्या है Experts का कहना इस वीडियो में. जानें किन Levels पर करना चाहिए आपको खरीदारी और क्या है Target Price, देखें वीडियो. 

#CNBCAwaaz #Sanofi #SanofiShareNews #CNBCAwaazLive #BusinessNewsLive #AajKaTajaKhabar #StockMarketLive #ShareMarketLive


CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://bit.ly/3230WJW

Sanofi India Share News: जानें Q4 के नतीजे के बाद क्या है Stock में निवेश को लेकर राय |Kamai Ka Adda

Sanofi India standalone net profit rises 63.40% in the March 2022 quarter

Sanofi India rose 1.68% to Rs 7,097 after the company’s standalone net profit surged 63.39% to Rs 238.40 crore on a 2.49% fall in revenue from operations to Rs 707 crore in Q1 March 2022 over Q1 March 2021.

Sanofi India gains after Q1 PAT grows 63% to Rs 238 cr

Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today.

Share Market Live: Sensex, Nifty Gain; Sanofi India Gains Most In Over A Month

Buzzing Stocks: ACC, L&T Infotech, Tata Steel Long, Wipro, Sanofi India, Sterlite Power, Ujjivan Financial, RVNL, SJVN

Stocks that will see action today

Rodolfo Hrosz will transition from being Sanofi’s General Manager, Consumer Healthcare business in Brazil to his new role in India as soon as the applicable regulatory approvals are in place, Sanofi India said in a statement.

Sanofi India names Rodolfo Hrosz as new Managing Director

He will transition from being Sanofi’s GM, Consumer Healthcare business in Brazil to the new role in India as soon as regulatory approvals are in place

Sanofi India names Rodolfo Hrosz managing director effective June 1

Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.

Sanofi India Ltd

Sanofi India Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Oman eyes PTA with India; to boost India’s trade ties with Gulf after UAE CEPA

Sanofi India: Strong balance sheet, high cash reserves positives for stock

Hold Sanofi India; target of Rs 7740: ICICI Direct

Buy Sanofi India: target of Rs 9250: Sharekhan

News Video

Sanofi India Share News: जानें Q4 के नतीजे के बाद क्या है Stock में निवेश को लेकर राय |Kamai Ka Adda

Sanofi India standalone net profit rises 63.40% in the March 2022 quarter

Sanofi India gains after Q1 PAT grows 63% to Rs 238 cr

Sanofi India Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Oman eyes PTA with India; to boost India’s trade ties with Gulf after UAE CEPA

Sanofi India: Strong balance sheet, high cash reserves positives for stock

Hold Sanofi India; target of Rs 7740: ICICI Direct

Buy Sanofi India: target of Rs 9250: Sharekhan

News Video

Sanofi India Share News: जानें Q4 के नतीजे के बाद क्या है Stock में निवेश को लेकर राय |Kamai Ka Adda

Sanofi India standalone net profit rises 63.40% in the March 2022 quarter

Sanofi India gains after Q1 PAT grows 63% to Rs 238 cr

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock